NCCN Releases New Guidelines for Pediatric Bone Sarcoma Treatment to Aid Families#USA#Plymouth_Meeting#NCCN#Ewing_Sarcoma#Pediatric_Bone_Sarcoma
NCCN Releases New Guidelines for Pediatric Bone Sarcoma Treatment to Aid Families
The National Comprehensive Cancer Network has published the first-ever NCCN Guidelines for Pediatric Bone Sarcoma, especially focusing on Ewing sarcoma, to support optimal care for affected children and families.
third-news.com
October 1, 2026 at 1:56 PM
NCCN Releases New Guidelines for Pediatric Bone Sarcoma Treatment to Aid Families#USA#Plymouth_Meeting#NCCN#Ewing_Sarcoma#Pediatric_Bone_Sarcoma
Very pleased to share our last collaborative publication with Child team #CRCI2NA @inserm.fr @insermgrandouest.bsky.social #cancéropole_Grand_Ouest #Ewing_sarcoma #KCNA2 #Kv1.2 #EWS::FLI1 #YAP/Hippo
biosignaling.biomedcentral.com/articles/10....
biosignaling.biomedcentral.com/articles/10....
Transcriptional regulation of KCNA2 coding Kv1.2 by EWS::FLI1: involvement in controlling the YAP/Hippo signalling pathway and cell proliferation - Cell Communication and Signaling
Background Ewing sarcoma (ES), the second main pediatric bone sarcoma, is characterised by a chromosomal translocation leading to the formation of fusion proteins like EWS::FLI1. While several studies...
biosignaling.biomedcentral.com
February 19, 2025 at 9:15 AM
Very pleased to share our last collaborative publication with Child team #CRCI2NA @inserm.fr @insermgrandouest.bsky.social #cancéropole_Grand_Ouest #Ewing_sarcoma #KCNA2 #Kv1.2 #EWS::FLI1 #YAP/Hippo
biosignaling.biomedcentral.com/articles/10....
biosignaling.biomedcentral.com/articles/10....
Fannin Partners Secures Major Grants for Ewing Sarcoma Drug Development#USA#Houston#Ewing_Sarcoma#Fannin_Partners#RapDC_Therapy
Fannin Partners Secures Major Grants for Ewing Sarcoma Drug Development
Fannin Partners has received significant grants to enhance a novel therapy targeting Ewing sarcoma, a rare pediatric cancer with few treatment options.
third-news.com
August 14, 2026 at 12:58 PM
Fannin Partners Secures Major Grants for Ewing Sarcoma Drug Development#USA#Houston#Ewing_Sarcoma#Fannin_Partners#RapDC_Therapy
Inhibrx Biosciences Set to Showcase Innovative Research at ESMO Congress#USA#San_Diego#Inhibrx#ESMO_Congress#Ewing_Sarcoma
Inhibrx Biosciences Set to Showcase Innovative Research at ESMO Congress
Inhibrx Biosciences is preparing to present groundbreaking findings on a novel drug combination for Ewing Sarcoma at the ESMO conference in March 2026.
third-news.com
March 2, 2026 at 9:06 PM
Inhibrx Biosciences Set to Showcase Innovative Research at ESMO Congress#USA#San_Diego#Inhibrx#ESMO_Congress#Ewing_Sarcoma